Overview
I am an Orthopaedic Oncologist, with dual clinical degrees (MD and DVM). I treat complex sarcomas in people and animals. My laboratory studies comparative oncology - discoveries we can make about cancer by analyses across different species.
Office Hours
Although I am always happy for people to drop by, my office hours vary by week. Please email me at w.eward@alumni.duke.edu.
Current Appointments & Affiliations
Frank H. Bassett III, M. D. Associate Professor of Orthopaedic Surgery
·
2022 - Present
Orthopaedic Surgery,
Clinical Science Departments
Associate Professor of Orthopaedic Surgery
·
2023 - Present
Orthopaedic Surgery,
Clinical Science Departments
Associate Professor of Pathology
·
2022 - Present
Pathology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2013 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Rethinking Residency Selection: Beyond Test Scores and Prestige.
Journal Article J Bone Joint Surg Am · March 4, 2026 Full text Link to item CiteFinancial Toxicity among Survivors of Extremity and Pelvic Sarcoma: A Retrospective Study.
Journal Article Ann Surg Oncol · March 2026 BACKGROUND: Financial toxicity in oncology, defined as the economic burden and psychosocial distress of cancer care, has been associated with poor clinical outcomes. Despite high projected treatment costs, data on financial toxicity in patients with sarcom ... Full text Link to item CiteKeratin-positive giant cell-rich tumor with HMGA::NCOR2 fusion in a 4-year-old.
Journal Article Skeletal Radiol · March 2026 Epiphyseal and metaphyseal bone lesions in pediatric patients are uncommon, and lesions that cross an open physis are even rarer. The differential diagnosis for such lesions consists of infection, giant cell tumor, and chondroblastoma. We describe a 4-year ... Full text Link to item CiteRecent Grants
Does the use of the reamer-irrigator-aspirator (RIA) during prophylactic intramedullary nailing attenuate the rise of circulating tumor cells?
Clinical TrialPrincipal Investigator · Awarded by Medical Device Business Services, Inc. · 2025 - 2030XPO1 and proteasome inhibition as a novel therapeutic combination in osteosarcoma
ResearchCo Investigator · Awarded by The Paula Takacs Foundation For Sarcoma Research · 2026 - 2027Phase 1 Study of X-PACT (X-ray Psoralen Activated Cancer Therapy)
Clinical TrialPrincipal Investigator · Awarded by Immunolight, LLC · 2021 - 2027View All Grants
Education
University of Vermont, College of Medicine ·
2006
M.D.